newsfilter
← Latest News
GlobeNewswire·

Hepion Pharmaceuticals to Present Two Posters at EASL International Liver Congress™ 2023

- Preclinical studies demonstrate rencofilstat may protect against NASH/NAFLD, shift the liver transcriptome and lipidome toward NASH resolution – - Cyclophilin B inhibition confirmed as an important target for